TG Therapeutics Shares Fall on EPS Miss Despite Strong BRIUMVI Sales and Raised Guidance
TG Therapeutics saw strong BRIUMVI sales and raised forecasts, but higher costs caused a major earnings miss, pushing shares lower.
TG Therapeutics saw strong BRIUMVI sales and raised forecasts, but higher costs caused a major earnings miss, pushing shares lower.
The AI platform detects scams and account takeovers in real time, protecting 760 million users.
T1 Energy will supply Clearway with U.S.-made solar modules, boosting American production and building a stronger domestic solar supply chain.
Flotek stock climbs 9% on a $400M backlog from a 10-year deal supplying power gear and smart systems for Puerto Rico’s energy crisis.
Stronger deliveries and analyst support are in focus.
China’s CXMT is considering a new memory-chip factory in Beijing using IPO funds, putting pressure on Micron and SK Hynix as it aims to double production capacity.